NARA Discovery
Article Details
← Back to Search Results
Journal Article

Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study

Martijn P. A. Starmans; Florian E. Buisman; Michel Renckens; François E. J. A. Willemssen; Sebastian R. van der Voort; Bas Groot Koerkamp; Dirk J. Grünhagen; Wiro J. Niessen; Peter B. Vermeulen; Cornelis Verhoef; Jacob J. Visser; Stefan Klein
Clinical & Experimental Metastasis · Vol. 38, Issue 5 · pp. 483-494 · 2021

Abstract

Histopathological growth patterns (HGPs) are independent prognosticators for colorectal liver metastases (CRLM). Currently, HGPs are determined postoperatively. In this study, we evaluated radiomics for preoperative prediction of HGPs on computed tomography (CT), and its robustness to segmentation and acquisition variations. Patients with pure HGPs [i.e. 100% desmoplastic (dHGP) or 100% replacement (rHGP)] and a CT-scan who were surgically treated at the Erasmus MC between 2003–2015 were included retrospectively. Each lesion was segmented by three clinicians and a convolutional neural network (CNN). A prediction model was created using 564 radiomics features and a combination of machine learning approaches by training on the clinician’s and testing on the unseen CNN segmentations. The intra-class correlation coefficient (ICC) was used to select features robust to segmentation variations; ComBat was used to harmonize for acquisition variations. Evaluation was performed through a 100 × random-split cross-validation. The study included 93 CRLM in 76 patients (48% dHGP; 52% rHGP). Despite substantial differences between the segmentations of the three clinicians and the CNN, the radiomics model had a mean area under the curve of 0.69. ICC-based feature selection or ComBat yielded no improvement. Concluding, the combination of a CNN for segmentation and radiomics for classification has potential for automatically distinguishing dHGPs from rHGP, and is robust to segmentation and acquisition variations. Pending further optimization, including extension to mixed HGPs, our model may serve as a preoperative addition to postoperative HGP assessment, enabling further exploitation of HGPs as a biomarker.

Bibliographic Information

JournalClinical & Experimental Metastasis
PublisherSpringer
Publication Date2021-10-01
Publication Year2021
Volume38
Issue5
Pages483-494
Document TypeJournal Article
eISSN1573-7276
DOI10.1007/s10585-021-10119-6

Access Information

NARA Access Coverage1983-01-01~Current
Journal Homepagehttps://www.springer.com/journal/10585
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.